Sign in
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Should Baseline Characteristics Affect Choice of Treatment?
Susan B. Bressler, MD, FASRS
Annual Meeting Talks
2018
Initial Results from the LADDER Trial
Carl C. Awh, MD, FASRS
Ananda Kalevar, MD, FRCS(C), DABO
Member Podcasts
Prospective Evaluation of Pain and Inflammation Following Injection of Aflibercept or Ranibizumab in Patients With Diabetic Macular Edema: SOLAR Study
Nikolas JS London, MD, FACS, FASRS
Category: Instrumentation and Devices